المؤلفون: Royal Free Hospital, London, UK ; Boston University School of Medicine, Boston, Massachusetts ; University of California, Los Angeles ; Leeds University, Leeds, UK ; University of Medicine and Dentistry of New Jersey, New Brunswick ; Genzyme, Boston, Massachusetts ; Cambridge Antibody Technology, Cambridge, UK ; Lund University Hospital, Lund, Sweden ; Walsgrave Hospital, Coventry, UK ; University Hospital, Nijmegen, The Netherlands ; Hope Hospital, Salford, UK ; University of Texas Health Science Center at Houston ; St. Vincent's Hospital, Dublin, Ireland ; University of Michigan, Ann Arbor ; Dr. Korn is deceased., University of Michigan, Ann Arbor, Royal Free Hospital, London, UK ; Centre for Rheumatology, Royal Free and University College Medical School, Royal Free Hospital, Pond Street, London NW3 2QG, UK, Boston University School of Medicine, Boston, Massachusetts, University of California, Los Angeles, Leeds University, Leeds, UK, University of Medicine and Dentistry of New Jersey, New Brunswick, Genzyme, Boston, Massachusetts ; Drs. Silliman, Streisand, Haas, and Ledbetter own stock and/or hold stock options in Genzyme. Dr. Powell owns stock and/or holds stock options in Cambridge Antibody Technology. Dr. van den Hoogen has received consulting fees and/or honoraria (less than $10,000 each) from Abbott and Bristol-Myers Squibb. Dr. Mayes has received consulting fees or honoraria (less than $10,000 each) from Actelion, Encysive, and Novartis., Genzyme, Boston, Massachusetts, Cambridge Antibody Technology, Cambridge, UK, Lund University Hospital, Lund, Sweden, Walsgrave Hospital, Coventry, UK, University Hospital, Nijmegen, The Netherlands, Hope Hospital, Salford, UK, University of Texas Health Science Center at Houston, St. Vincent's Hospital, Dublin, Ireland, Royal Free Hospital, London, UK, Denton, Christopher P., Merkel, Peter A., Furst, Daniel E., Khanna, Dinesh, Emery, Paul, Hsu, Vivien M., Silliman, Nancy, Streisand, James, Powell, John, Åkesson, Anita, Coppock, John, Hoogen, Frank van den, Herrick, Ariane, Mayes, Maureen D., Veale, Douglas, Haas, Joanna, Ledbetter, Stephen, Korn, Joseph H., Black, Carol M., Seibold, James R.

URL: http://hdl.handle.net/2027.42/55924
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17195236&dopt=citation

المؤلفون: B. Labar1, S. Suciu2, P. Muus3, R. Willemze4, J.-P. Marie5, G. Fillet6, Z. Berneman7, B. Jaksic8, W. Feremans9, D. Bron10, H. Sinnige11, M. Mistrik12, G. Vreugdenhil13, R. De Bock14, D. Nemet1, C. Gilotay2, T. De Witte3, S. Amadori15 1 University Hospital Center Rebro, Zagreb, Croatia 2 EORTC Data Center, Brussels, Belgium 3 St. Radboud University Hospital, Nijmegen, The Netherlands 4 Leiden University Hospital, Leiden, The Netherlands 5 Hotel-Dieu de Paris, Paris, France 6 CHU Sart-Tilman, Liege, Belgium 7 Universitair Ziekenhuis Antwerpen, Antwerpen, Belgium 8 Clinical Hospital Merkur, Zagreb, Croatia 9 Hopital Universitaire Erasme, Brussels, Belgium 10 Institut Jules Bordet, Brussels, Belgium 11 Groot Ziekengasthuis, Den Bosch, Netherlands 12 University Hospital, Bratislava, Slovakia (Slovak Republic) 13 St. Josef Ziekenhuis, Veldhoven, The Netherlands 14 Algemeen Ziekenhuis Middelheim, Antwerpen, Belgium 15 Ospedale San Eugenio, Rome, Italy

مصطلحات موضوعية: EORTC

URL الوصول: https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::56aece38dee83e233afc2f834ffa761a
https://www.bib.irb.hr/277198

المؤلفون: University of Michigan Hospitals, Ann Arbor, Michigan, USA; Department of Urology, Radboud University Hospital, Nijmegen, The Netherlands., Feitz, Wouter E.J., Ritchey, Michael L., Bloom, David A.

URL: http://www.sciencedirect.com/science/article/B6VJW-4C548CC-2K/2/df86710dcbc46922f932aca388471a0b
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=8197649&dopt=citation
http://hdl.handle.net/2027.42/31559
https://doi.org/10.1016/0090-4295(94)90148-1

المؤلفون: Hol, F A, Geurds, M P, Jensson, O, Hamel, B C, Moore, G E, Newton, R, Mariman, E C

المساهمون: Department of Human Genetics, University Hospital Nijmegen, The Netherlands.

مصطلحات موضوعية: Chromosome Mapping, Female, Genetic Linkage, Haplotypes, Humans, Iceland, Male, Neural Tube Defects, Pedigree, X Chromosome

Relation: http://dx.doi.org/10.1007/BF00201674; Hum. Genet. 1994, 93(4):452-6; 8168816; http://hdl.handle.net/2336/122786; Human genetics

الاتاحة: http://hdl.handle.net/2336/122786
https://doi.org/10.1007/BF00201674

المؤلفون: Denton, Christopher P., Merkel, Peter A., Furst, Daniel E., Khanna, Dinesh, Emery, Paul, Hsu, Vivien M., Silliman, Nancy, Streisand, James, Powell, John, Åkesson, Anita, Coppock, John, Hoogen, Frank van den, Herrick, Ariane, Mayes, Maureen D., Veale, Douglas, Haas, Joanna, Ledbetter, Stephen, Korn, Joseph H., Black, Carol M., Seibold, James R.

المساهمون: Royal Free Hospital, London, UK, Boston University School of Medicine, Boston, Massachusetts, University of California, Los Angeles, Leeds University, Leeds, UK, University of Medicine and Dentistry of New Jersey, New Brunswick, Genzyme, Boston, Massachusetts, Cambridge Antibody Technology, Cambridge, UK, Lund University Hospital, Lund, Sweden, Walsgrave Hospital, Coventry, UK, University Hospital, Nijmegen, The Netherlands, Hope Hospital, Salford, UK, University of Texas Health Science Center at Houston, St. Vincent's Hospital, Dublin, Ireland, University of Michigan, Ann Arbor, Dr. Korn is deceased., Centre for Rheumatology, Royal Free and University College Medical School, Royal Free Hospital, Pond Street, London NW3 2QG, UK, Drs. Silliman, Streisand, Haas, and Ledbetter own stock and/or hold stock options in Genzyme. Dr. Powell owns stock and/or holds stock options in Cambridge Antibody Technology. Dr. van den Hoogen has received consulting fees and/or honoraria (less than $10,000 each) from Abbott and Bristol-Myers Squibb. Dr. Mayes has received consulting fees or honoraria (less than $10,000 each) from Actelion, Encysive, and Novartis.

مصطلحات موضوعية: Life and Medical Sciences, Geriatrics, Health Sciences

وصف الملف: 162817 bytes; 3118 bytes; application/pdf; text/plain

Relation: Denton, Christopher P.; Merkel, Peter A.; Furst, Daniel E.; Khanna, Dinesh; Emery, Paul; Hsu, Vivien M.; Silliman, Nancy; Streisand, James; Powell, John; Åkesson, Anita; Coppock, John; Hoogen, Frank van den; Herrick, Ariane; Mayes, Maureen D.; Veale, Douglas; Haas, Joanna; Ledbetter, Stephen; Korn, Joseph H.; Black, Carol M.; Seibold, James R. (2007). "Recombinant human anti–transforming growth factor Β1 antibody therapy in systemic sclerosis: A multicenter, randomized, placebo-controlled phase I/II trial of CAT-192." Arthritis & Rheumatism 56(1): 323-333.; https://hdl.handle.net/2027.42/55924; http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17195236&dopt=citation; http://dx.doi.org/10.1002/art.22289; Arthritis & Rheumatism

الاتاحة: https://hdl.handle.net/2027.42/55924
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17195236&dopt=citation
https://doi.org/10.1002/art.22289

المؤلفون: Grossman, Ashley, Pacak, Karel, Sawka, Anna, Lenders, Jacques W. M., Harlander, Debra, Peaston, Robert T., Reznek, Rodney, Sisson, James C., Eisenhofer, Graeme

المساهمون: Department of Radiology, University of Michigan Hospitals, Ann Arbor, Michigan 48109, USA, Department of Endocrinology, St. Bartholomew's Hospital, West Smithfield, London, UK, Reproductive Biology and Medicine Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892, USA, Department of Medicine, University of Toronto, Toronto, Ontario, Canada, Department of General Internal Medicine, St. Radboud University Hospital, Nijmegen, the Netherlands, Pheochromocytoma Support Group, Camden, New York 13316, USA, Department of Clinical Biochemistry, Freeman Hospital, Newcastle upon Tyne, UK, Division of Radiology, St. Bartholomew's Hospital, West Smithfield, London, UK, Clinical Neurocardiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892, USA

مصطلحات موضوعية: Pheochromocytoma, Biochemical Diagnosis, Metanephrines, Catecholamines, Localization, Computed Tomography, Magnetic Resonance Imaging, MIBG, Positron Emission Tomography, Science (General), Science

وصف الملف: 210611 bytes; 3109 bytes; application/pdf; text/plain

Relation: GROSSMAN, ASHLEY; PACAK, KAREL; SAWKA, ANNA; LENDERS, JACQUES W. M .; HARLANDER, DEBRA; PEASTON, ROBERT T .; REZNEK, RODNEY; SISSON, JAMES; EISENHOFER, GRAEME (2006). "Biochemical Diagnosis and Localization of Pheochromocytoma." Annals of the New York Academy of Sciences 1073(1 Pheochromocytoma: First International Symposium ): 332-347.; https://hdl.handle.net/2027.42/72111; http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17102103&dopt=citation; Annals of the New York Academy of Sciences; Platts, J.K., P.J. Drew & J.N. Harvey. 1995. Death from phaeochromocytoma: lessons from a post-mortem survey. J. Roy. Coll. Physicians Lond. 29: 299 – 306.; Lo, C.Y. et al. 2000. Adrenal pheochromocytoma remains a frequently overlooked diagnosis. Am. J. Surg. 179: 212 – 215.; McNeil, A.R. et al. 2000. Phaeochromocytomas discovered during coronial autopsies in Sydney, Melbourne and Auckland. Aust. N. Z. J. Med. 30: 648 – 652.; Kaltsas, G.A., D. Papadogias & A.B. Grossman. 2004. The clinical presentation (symptoms and signs) of sporadic and familial chromaffin cell tumours (phaeochromocytomas and paragangliomas). Front. Horm. Res. 31: 61 – 75.; Sjoerdsma, A. et al. 1959. Studies on the biogenesis and metabolism of norepinephrine in patients with pheochromocytoma. J. Clin. Invest. 38: 31 – 38.; Crout, J.R. & A. Sjoerdsma. 1964. Turnover and metabolism of catecholamines in patients with pheochromocytoma. J. Clin. Invest. 43: 94 – 102.; Eisenhofer, G. et al. 2003. Pheochromocytoma: rediscovery as a catecholamine-metabolizing tumor. Endocr. Pathol. 14: 193 – 212.; Eisenhofer, G. et al. 1999. Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. N. Engl. J. Med. 340: 1872 – 1879.; Raber, W. et al. 2000. Diagnostic efficacy of unconjugated plasma metanephrines for the detection of pheochromocytoma. Arch. Intern. Med. 160: 2957 – 2963.; Lenders, J.W. et al. 2002. Biochemical diagnosis of pheochromocytoma: which test is best ? JAMA 287: 1427 – 1434.; Sawka, A.M. et al. 2003. A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J. Clin. Endocrinol. Metab. 88: 553 – 558.; Sawka, A.M. et al. 2004. A systematic review of the literature examining the diagnostic efficacy of measurement of fractionated plasma free metanephrines in the biochemical diagnosis of pheochromocytoma. BMC Endocr. Disord. 4: 2.; Unger, N. et al. 2006. Diagnostic value of various biochemical parameters for the diagnosis of pheochromocytoma in patients with adrenal mass. Eur. J. Endocrinol. 154: 409 – 417.; Gardet, V. et al. 2001. Lessons from an unpleasant surprise: a biochemical strategy for the diagnosis of pheochromocytoma. J. Hypertens. 19: 1029 – 1035.; Gerlo, E.A. & C. Sevens. 1994. Urinary and plasma catecholamines and urinary catecholamine metabolites in pheochromocytoma: diagnostic value in 19 cases. Clin. Chem. 40: 250 – 256.; Davidson, D.F. 2002. Phaeochromocytoma with normal urinary catecholamines: the potential value of urinary free metadrenalines. Ann. Clin. Biochem. 39: 557 – 566.; Guller, U. et al. 2006. Detecting pheochromocytoma: defining the most sensitive test. Ann. Surg. 243: 102 – 107.; Sawka, A.M. et al. 2004. The economic implications of three biochemical screening algorithms for pheochromocytoma. J. Clin. Endocrinol. Metab. 89: 2859 – 2866.; Brown, M.J. & D.J. Allison. 1981. Renal conversion of plasma DOPA to urine dopamine. Br. J. Clin. Pharmacol. 12: 251 – 253.; Eisenhofer, G. et al. 2005. Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine. J. Clin. Endocrinol. Metab. 90: 2068 – 2075.; Ross, G.A. et al. 1993. Plasma and 24 h-urinary catecholamine concentrations in normal and patient populations. Ann. Clin. Biochem. 30 ( Pt. 1 ): 38 – 44.; Sawka, A.M. et al. 2005. Measurement of fractionated plasma metanephrines for exclusion of pheochromocytoma: can specificity be improved by adjustment for age ? BMC Endocr. Disord. 5: 1.; Eisenhofer, G. et al. 1995. Plasma metadrenalines: do they provide useful information about sympatho-adrenal function and catecholamine metabolism ? Clin. Sci. (Lond.) 88: 533 – 542.; Eisenhofer, G. et al. 2003. Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results. J. Clin. Endocrinol. Metab. 88: 2656 – 2666.; Brown, M.J. et al. 1981. Increased sensitivity and accuracy of phaeochromocytoma diagnosis achieved by use of plasma-adrenaline estimations and a pentolinium-suppression test. Lancet 1: 174 – 177.; Bravo, E.L. et al. 1981. Clonidine-suppression test: a useful aid in the diagnosis of pheochromocytoma. N. Engl. J. Med. 305: 623 – 626.; Mulinari, R.A. et al. 1987. The clonidine test for the diagnosis of pheochromocytoma: the usefulness of urinary metanephrine measurements. Braz. J. Med. Biol. Res. 20: 43 – 46.; Neumann, H.P. et al. 2002. Germ-line mutations in nonsyndromic pheochromocytoma. N. Engl. J. Med. 346: 1459 – 1466.; Amar, L. et al. 2005. Genetic testing in pheochromocytoma or functional paraganglioma. J. Clin. Oncol. 23: 8812 – 8818.; Remine, W. et al. 1974. Current management of pheochromocytoma. Ann. Surg. 179: 740 – 748.; Troncone, L. et al. 1990. The diagnostic and therapeutic utility of radioiodinated metaiodobenzylguanidine (MIBG): 5 years of experience. Eur. J. Nucl. Med. 16: 325 – 335.; Peppercorn, P.D., A.B. Grossman & R.H. Reznek. 1998. Imaging of incidentally discovered adrenal masses. Clin. Endocrinol. (Oxford) 48: 379 – 388.; Grumbach, M.M. et al. 2003. Management of the clinically inapparent adrenal mass (“incidentaloma”). Ann. Intern. Med. 138: 424 – 429.; Eisenhofer, G. et al. 2005. Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines. Clin. Chem. 51: 735 – 744.; Francis, I. & M. Korobkin. 1996. Pheochromocytoma. Adv. Uroradiol. 34: 1101 – 1112.; Goldstein, R.E. et al. 1999. Clinical experience over 48 years with pheochromocytoma. Ann. Surg. 229: 755 – 764; discussion 764–766.; Sahdev, A. et al. 2005. CT and MR imaging of unusual locations of extra-adrenal paragangliomas (pheochromocytomas). Eur. Radiol. 15: 85 – 92.; Mukherjee, J.J. et al. 1997. Pheochromocytoma: effect of nonionic contrast medium in CT on circulating catecholamine levels. Radiology 202: 227 – 231.; Quint, L.E. et al. 1987. Pheochromocytoma and paraganglioma: comparison of MR imaging with CT and I-131 MIBG scintigraphy. Radiology 165: 89 – 93.; Varghese, J.C. et al. 1997. MR differentiation of phaeochromocytoma from other adrenal lesions based on qualitative analysis of T2 relaxation times. Clin. Radiol. 52: 603 – 606.; Furuta, N. et al. 1999. Diagnosis of pheochromocytoma using [123I]-compared with [131I]-metaiodobenzylguanidine scintigraphy. Int. J. Urol. 6: 119 – 124.; Ilias, I., B. Shulkin & K. Pacak. 2005. New functional imaging modalities for chromaffin tumors, neuroblastomas and ganglioneuromas. Trends Endocrinol. Metab. 16: 66 – 72.; Miskulin, J. et al. 2003. Is preoperative iodine 123 meta-iodobenzylguanidine scintigraphy routinely necessary before initial adrenalectomy for pheochromocytoma ? Surgery 134: 918 – 922; discussion 922–923.; Hoegerle, S. et al. 2002. Pheochromocytomas: detection with 18F DOPA whole body PET: initial results. Radiology. 222: 507 – 512.; Pacak, K. et al. 2001. 6-[18F]fluorodopamine positron emission tomographic (PET) scanning for diagnostic localization of pheochromocytoma. Hypertension 38: 6 – 8.; Shulkin, B.L. et al. 1999. Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-d-glucose PET. Nucl. Med. 212: 35 – 41.; Mann, G.N. et al. 2006. [(11)C]metahydroxyephedrine and [(18)F]Fluorodeoxyglucose positron emission tomography improve clinical decision making in suspected pheochromocytoma. Ann. Surg. Oncol. 13: 187 – 197.; Trampal, C. et al. 2004. Pheochromocytomas: detection with 11C hydroxyephedrine PET. Radiology 230: 423 – 428.; Mediavilla Garcia, J.D. et al. 1999. A comparative study of 9 cases of adrenal pheochromocytoma and 11 cases of extra-adrenal pheochromocytoma. Rev. Clin. Esp. 199: 343 – 348.; Kaltsas, G. et al. 2001. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors. J. Clin. Endocrinol. Metab. 86: 895 – 902.; Chew, S.L. et al. 1994. Bilateral phaeochromocytomas in von Hippel-Lindau disease: diagnosis by adrenal vein sampling and catecholamine assay. Q. J. Med. 87: 49 – 54.; Pacak, K. et al. 2001. A “pheo” lurks: novel approaches for locating occult pheochromocytoma. J. Clin. Endocrinol. Metab. 86: 3641 – 3646.

الاتاحة: https://hdl.handle.net/2027.42/72111
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17102103&dopt=citation
https://doi.org/10.1196/annals.1353.038

المؤلفون: Feitz, Wouter E. J., Ritchey, Michael L., Bloom, David A.

المساهمون: University of Michigan Hospitals, Ann Arbor, Michigan, USA, Department of Urology, Radboud University Hospital, Nijmegen, The Netherlands.

مصطلحات موضوعية: Internal Medicine and Specialties, Health Sciences

وصف الملف: 271984 bytes; 3118 bytes; application/pdf; text/plain

Relation: Feitz, Wouter E. J., Ritchey, Michael L., Bloom, David A. (1994/06)."Ureterocele associated with a single collecting system of the involved kidney." Urology 43(6): 849-851.; http://www.sciencedirect.com/science/article/B6VJW-4C548CC-2K/2/df86710dcbc46922f932aca388471a0b; http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=8197649&dopt=citation; https://hdl.handle.net/2027.42/31559; 8197649; http://dx.doi.org/10.1016/0090-4295(94)90148-1; Urology

الاتاحة: https://hdl.handle.net/2027.42/31559
http://www.sciencedirect.com/science/article/B6VJW-4C548CC-2K/2/df86710dcbc46922f932aca388471a0b
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=8197649&dopt=citation
https://doi.org/10.1016/0090-4295(94)90148-1

المؤلفون: Wagener, D J, Somers, R, Santoro, A, Verweij, J, Woll, Penella J, Blackledge, G, Schütte, H J, Lentz, M A, Van Glabbeke, M

المساهمون: Division of Medical Oncology, Radboud University Hospital, Nijmegen, The Netherlands.

مصطلحات موضوعية: Liver Cancer, Lung Cancer, Adult, Aged, Drug Evaluation, Female, Humans, Leukopenia, Liver Neoplasms, Lung Neoplasms, Male, Middle Aged, Nimustine, Sarcoma, Thrombocytopenia

Relation: Phase II study of nimustine in metastatic soft tissue sarcoma. European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma. 1991, 27 (12):1604-5 Eur. J. Cancer; 1782068; http://hdl.handle.net/10541/108783; European Journal of Cancer

الاتاحة: http://hdl.handle.net/10541/108783